MoonLake Immunotherapeutics (MLTX) Current Leases (2022 - 2026)

MoonLake Immunotherapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $920000.0 for Q1 2026.

• In Q1 2026, Current Leases fell 35.75% year-over-year to $920000.0; the TTM figure through Mar 2026 stood at $920000.0 (down 35.75% YoY), while the FY2025 annual figure was $1.2 million, down 10.06% from the prior year.
• Current Leases was $920000.0 for Q1 2026 at MoonLake Immunotherapeutics, down from $1.2 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.5 million in Q2 2025 to a low of $153629.0 in Q4 2022.
• Historically, Current Leases has averaged $992805.9 across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Current Leases surged 824.21% in 2024, then plunged 35.75% in 2026.
• A 5-year view of Current Leases shows it stood at $153629.0 in 2022, then jumped by 679.72% to $1.2 million in 2023, then gained by 14.54% to $1.4 million in 2024, then retreated by 10.06% to $1.2 million in 2025, then retreated by 25.45% to $920000.0 in 2026.
• The last three Current Leases figures came in at $920000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.